Erratum to: Factors predicting survival after post‐transplant hepatocellular carcinoma recurrence

Publisher： John Wiley & Sons Inc

E-ISSN： 1868-6982|20|5|547-548

ISSN： 1868-6974

Source： JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol.20, Iss.5, 2013-06, pp. : 547-548

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factors predicting survival after post‐transplant hepatocellular carcinoma recurrence

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 20, Iss. 3, 2013-03 ,pp. : 342-347

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply to: Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 4, 2015-04 ,pp. : 503-504

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time to resize the role of everolimus as treatment of hepatocellular carcinoma recurrence after liver transplant

By  

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 4, 2015-04 ,pp. : 502-502

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combinations of biomarkers and Milan criteria for predicting hepatocellular carcinoma recurrence after liver transplantation

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 5, 2015-05 ,pp. : 599-606

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognosis after recurrence of hepatocellular carcinoma in liver transplantation: predictors for successful treatment and survival

By  

CLINICAL TRANSPLANTATION (ELECTRONIC), Vol. 29, Iss. 12, 2015-12 ,pp. : 1156-1163

John Wiley & Sons Inc

Access to resources Recommend Favorite